TY  - GEN
AU  - Maoz,Myriam
AU  - Devir,Michal
AU  - Inbar,Michal
AU  - Inbar-Daniel,Ziva
AU  - Sherill-Rofe,Dana
AU  - Bloch,Idit
AU  - Meir,Karen
AU  - Edelman,David
AU  - Azzam,Salah
AU  - Nechushtan,Hovav
AU  - Maimon,Ofra
AU  - Uziely,Beatrice
AU  - Kadouri,Luna
AU  - Sonnenblick,Amir
AU  - Eden,Amir
AU  - Peretz,Tamar
AU  - Zick,Aviad
TI  - Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes
SN  - 2045-2322
PY  - 2020///1106
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Cell Line, Tumor
KW  - Disease Progression
KW  - Enzyme Inhibitors
KW  - Female
KW  - Gene Amplification
KW  - Genes, erbB-2
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - classification
KW  - Polymerase Chain Reaction
KW  - Protein Phosphatase 2C
KW  - antagonists & inhibitors
KW  - Receptor, ErbB-2
KW  - genetics
KW  - Whole Genome Sequencing
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/s41598-019-55455-6
ER  -